Combined Pre- and Post-capillary Pulmonary Hypertension
📧 Sign up to get email alerts when something new happens for Combined Pre- and Post-capillary Pulmonary Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) [Phase 2]
Phase 2 clinical trial update for sotatercept in combined pre- and post-capillary pulmonary hypertension due to heart failure with preserved…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) [Phase 4]
Phase 4 trial evaluating concomitant administration of macitentan and dapagliflozin in patients with heart failure with mid-range and preser…